Evotec SE - ADR (EVO) Company Profile & Statistics

Evotec SE - ADR
EVO
(Nasdaq - US)
N/A
5.27
+0.08 (+1.54%)
in:usd•As of: May 09, 2024 15:59 UTC -4
Open
5.18
High
5.27
Low
5.18

About Evotec SE - ADR

CEO

Werner Lanthaler

Headquarters

essener bogen 7

hamburg, 2m 22419, germany

Auditor

BDO AG Wirtschaftspr¿fungsgesellschaft

Employees

4,952

Share Holders

N/A

Website

www.evotec.com

Industry

pharmaceuticals major

Sector

health technology

Company Overview

EVOTEC is a leader in the discovery and development of novel small molecule drugs. They have established a powerful platform that is applicable to targets across all therapeutic areas and has specific expertise in the area of Central Nervous System related diseases where it is building a pipeline of drug candidates for partnering. Through research collaborations and proprietary projects They are providing the highest quality research results to its partners in the pharmaceutical and biotechnology industries

Evotec SE - ADR Statistics

Valuation Measures

Market Capitalization ²	1.87B
Enterprise Value	1.32B
Enterprise Value/EBITDA (ttm)	-96.38
Price to Earnings Ratio (ttm)	N/A
Price to Book (mrq)	1.47
Price to Sales (ttm)	N/A
Price to Cash (ytd)	N/A

Profitability

Gross Margin (ttm)	25.14%
Operating Margin (ttm)	N/A
Profit Margin (ttm)	-20.84%
Return on Equity (ttm)	N/A
Return on Invested Capital (ttm)	-9.94%
Return on Assets (ttm)	N/A

Income Statement

Revenue (ttm)	647.84M
Revenue Per Share (ttm)	N/A
Gross Profit (ttm)	177.33M
EBITDA (ttm)³	-13.75M
Net Income Avi to Common (ttm)	-84.21M
Diluted EPS (ttm)	N/A

Share Statistics

Beta (5Y Monthly)	1.46
52-Week Change	-43.64%
S&P500 52-Week Change	26.58%
S&P500 Member	No
Stock Optionable	No
Total Shares Outstanding ¹	N/A
Dividend Yield	0.00%
Float ⁴	350.83M
% Held by Insiders	1.00%
% Held by Institutions	5.81%

Balance Sheet

Total Cash (mrq)	667.59M
Total Cash Per Share (mrq)	N/A
Total Debt (mrq)	926.20K
Total Debt/Equity (mrq)	0.07%
Current Ratio (mrq)	2.16%
Quick Ratio (mrq)	2.09%
Book Value Per Share (mrq)	14.02

Cash Flow

Operating Cash Flow Per Share (ytd)	0.19
Free Cash Flow (ytd)	-146.69M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. Stock price provided by Xignite. All numbers are rounded to the closest decimal.

¹ Total Shares outstanding is taken from the most recently filed quarterly or annual report.

² Market Cap is calculated using total shares outstanding and the most recent share price.

³ EBITDA is calculated using methodology that may differ from that used by a company in its reporting.

⁴ The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.

Evotec SE - ADR

Trade With A Regulated Broker